Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue
by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI
Updated on: February 18,2024
18
Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue
by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI
Updated on:February 18,2024
18
